Meta-analysis of the effect of singing therapy on patients with chronic obstructive pulmonary disease
10.3760/cma.j.cn115682-20231122-02198
- VernacularTitle:歌唱疗法在慢性阻塞性肺疾病患者应用效果中的Meta分析
- Author:
Nuan XU
1
;
Purui YANG
;
Mingxin CAO
;
Aimin GUO
Author Information
1. 兰州大学护理学院，兰州 730011
- Keywords:
Pulmonary disease, chronic obstructive;
Singing therapy;
Meta analysis
- From:
Chinese Journal of Modern Nursing
2024;30(9):1181-1189
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To systematically evaluate the effect of singing therapy on patients with chronic obstructive pulmonary disease.Methods:Randomized controlled trials on the effect of singing therapy in patients with chronic obstructive pulmonary disease were searched by computer from PubMed, Web of Science, Cochrane Library, CINAHL, Embase, China National Knowledge Infrastructure, Wanfang Data, China Biology Medicine disc, and VIP. The search period was from the establishment of databases to June 30, 2023. Two researchers independently screened literature, performed a literature quality assessment, and extracted data. Meta-analysis was performed using RevMan 5.4 software.Results:A total of 11 articles were included. Meta-analysis showed that singing therapy for 10 weeks or more could improved anxiety ( MD=-5.01, 95% CI: -5.76~-4.25, P<0.001), and depression ( MD=-4.73, 95% CI: -8.82~-0.64, P=0.020). Singing therapy with a duration of less than 60 min per session and/or five interventions per week or more could improve FEV 1% predicted values ( MD=9.46, 95% CI: 7.66~11.26, P<0.001) in patients with chronic obstructive pulmonary disease. Conclusions:Singing therapy is best achieved at least five times a week, with each session lasting less than 60 minutes and lasting for at least ten weeks. However, more high-quality, multicenter and large sample studies are still needed for further validation.
